[{"id":"f636bd6e-d960-4b98-8bc3-4153df68b48f","acronym":"","url":"https://clinicaltrials.gov/study/NCT02334735","created_at":"2021-01-29T07:07:33.888Z","updated_at":"2024-07-02T16:36:03.853Z","phase":"Phase 2","brief_title":"A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence","source_id_and_acronym":"NCT02334735","lead_sponsor":"Nina Bhardwaj","biomarkers":" CD8 • CTAG1B • CD4","pipe":"","alterations":" ","tags":["CD8 • CTAG1B • CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Hiltonol (poly-ICLC) • Poly-ICLC matured DC adjuvanted NY-ESO-1/Melan-A-MART-1 peptide vaccine"],"overall_status":"Completed","enrollment":" Enrollment 36","initiation":"Initiation: 07/01/2015","start_date":" 07/01/2015","primary_txt":" Primary completion: 07/15/2020","primary_completion_date":" 07/15/2020","study_txt":" Completion: 07/15/2020","study_completion_date":" 07/15/2020","last_update_posted":"2022-09-15"}]